I would have to agree with cake on this one. There is no reason for them to not tell us.
I think it is their only income and therefore a significant news.
Nine months already from the last recruited patient. If we are looking at 390 patients with trial stopping if 350 have disease progression then we know at least about 10 percent are still good. Hopefully no news on trial halting for Dec as this will be even greater news for us. Please note I didn't add the 25 patients as I am not sure if the 350 count should also go up.
ACL Price at posting:
62.0¢ Sentiment: Buy Disclosure: Held